North America Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity
Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. North America bioelectric medicine market is projected to grow by 7.0% annually in the forecast period and reach $15.82 billion by 2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 63 tables and 39 figures, this 136-page report “North America Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 63 tables and 39 figures, this 136-page report “North America Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Implantable Bioelectric Medicine
- Cardiac Pacemaker
- Implantable Cardioverter Defibrillators (ICD)
- Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
- Cochlear Implants
- Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
- Retinal Implants
- Other Implantable Bioelectric Medicines
- Non-invasive Bioelectric Medicine
- Transcutaneous Electrical Nerve Stimulators
- Transcranial Magnetic Stimulation (TMS)
- Pulsed Electromagnetic Field Therapy
- Other Non-invasive Bioelectric Medicines
- Hospitals and Clinics
- Research Institutes
- Individual Users
- U.S.
- Canada
- Mexico
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT TYPE
3.1 Market Overview by Product Type
3.2 Implantable Bioelectric Medicine
3.2.1 Cardiac Pacemaker
3.2.2 Implantable Cardioverter Defibrillators (ICD)
3.2.3 Spinal Cord Stimulators
3.2.4 Cochlear Implants
3.2.5 Deep Brain Stimulators
3.2.6 Vagus Nerve Stimulators
3.2.7 Sacral Nerve Stimulators
3.2.8 Retinal Implants
3.2.9 Other Implantable Bioelectric Medicines
3.3 Non-invasive Bioelectric Medicine
3.3.1 Transcutaneous Electrical Nerve Stimulators
3.3.2 Transcranial Magnetic Stimulation (TMS)
3.3.3 Pulsed Electromagnetic Field Therapy
3.3.4 Other Non-invasive Bioelectric Medicines
4 SEGMENTATION OF NORTH AMERICA MARKET BY END USER
4.1 Market Overview by End User
4.2 Hospitals and Clinics
4.3 Research Institutes
4.4 Individual Users
5 NORTH AMERICA MARKET 2020-2030 BY COUNTRY
5.1 Overview of North America Market
5.2 U.S.
5.3 Canada
5.4 Mexico
6 COMPETITIVE LANDSCAPE
6.1 Overview of Key Vendors
6.2 New Product Launch, Partnership, Investment, and M&A
6.3 Company Profiles
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
7 INVESTING IN NORTH AMERICA MARKET: RISK ASSESSMENT AND MANAGEMENT
7.1 Risk Evaluation of North America Market
7.2 Critical Success Factors (CSFs)
Related Reports and Products
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT TYPE
3.1 Market Overview by Product Type
3.2 Implantable Bioelectric Medicine
3.2.1 Cardiac Pacemaker
3.2.2 Implantable Cardioverter Defibrillators (ICD)
3.2.3 Spinal Cord Stimulators
3.2.4 Cochlear Implants
3.2.5 Deep Brain Stimulators
3.2.6 Vagus Nerve Stimulators
3.2.7 Sacral Nerve Stimulators
3.2.8 Retinal Implants
3.2.9 Other Implantable Bioelectric Medicines
3.3 Non-invasive Bioelectric Medicine
3.3.1 Transcutaneous Electrical Nerve Stimulators
3.3.2 Transcranial Magnetic Stimulation (TMS)
3.3.3 Pulsed Electromagnetic Field Therapy
3.3.4 Other Non-invasive Bioelectric Medicines
4 SEGMENTATION OF NORTH AMERICA MARKET BY END USER
4.1 Market Overview by End User
4.2 Hospitals and Clinics
4.3 Research Institutes
4.4 Individual Users
5 NORTH AMERICA MARKET 2020-2030 BY COUNTRY
5.1 Overview of North America Market
5.2 U.S.
5.3 Canada
5.4 Mexico
6 COMPETITIVE LANDSCAPE
6.1 Overview of Key Vendors
6.2 New Product Launch, Partnership, Investment, and M&A
6.3 Company Profiles
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
7 INVESTING IN NORTH AMERICA MARKET: RISK ASSESSMENT AND MANAGEMENT
7.1 Risk Evaluation of North America Market
7.2 Critical Success Factors (CSFs)
Related Reports and Products
LIST OF TABLES
Table 1. Snapshot of North America Bioelectric Medicine Market in Balanced Perspective, 2020-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Projection of North America Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Selected Examples of Product Recalls
Table 6. Main Product Trends and Market Opportunities in North America Bioelectric Medicine Market
Table 7. North America Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 8. North America Implantable Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 9. North America Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, $ mn
Table 10. North America Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, $ mn
Table 11. North America Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, $ mn
Table 12. North America Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 13. North America Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 14. North America Bioelectric Medicine Market by Country, 2019-2030, $ mn
Table 15. U.S. Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 16. U.S. Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 17. Canada Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 18. Canada Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 19. Mexico Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 20. Mexico Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 21. Spinal Cord Stimulation Device Market by Key Vendor, 2019, %
Table 22. Cochlear Implant Market by Key Vendor, 2019, %
Table 23. Pacemaker and ICD Market by Key Vendor, 2019, %
Table 24. FDA Approved Products of Key Vendors
Table 25. Abbott Laboratories: Company Snapshot
Table 26. Abbott Laboratories: Business Segmentation
Table 27. Abbott Laboratories: Product Portfolio
Table 28. Abbott Laboratories: Revenue, 2018-2020, $ mn
Table 29. BIOTRONIK SE & Co. KG: Company Snapshot
Table 30. Boston Scientific Corp.: Company Snapshot
Table 31. Boston Scientific Corp.: Business Segmentation
Table 32. Boston Scientific Corp.: Product Portfolio of Medical Devices
Table 33. Cochlear Limited: Company Snapshot
Table 34. Cochlear Limited: Operational Overview with Sales Revenue ($ mn) and Sales Volume (units), 2020-2021
Table 35. Cochlear Limited: Product Portfolio
Table 36. electroCore, Inc.: Company Snapshot
Table 37. Inspire Medical Systems, Inc..: Company Snapshot
Table 38. LivaNova PLC: Company Snapshot
Table 39. LivaNova PLC: Product Portfolio
Table 40. Medtronic Inc.: Company Snapshot
Table 41. Medtronic Inc.: Net Revenue by Segment, 2018-2020, $ bn
Table 42. Medtronic Inc.: Net Revenue by Region, 2017-2019, $ bn
Table 43. Medtronic Inc.: Product Portfolio of Medical Devices
Table 44. Medtronic Inc.: Product Portfolio of Bioelectric Medicine
Table 45. NeuroMetrix, Inc: Company Snapshot
Table 46. NeuroMetrix, Inc: Product Portfolio
Table 47. Nevro Corp.: Company Snapshot
Table 48. Nevro Corp.: Product Portfolio
Table 49. Nuvectra Corporation: Company Snapshot
Table 50. Omron Corporation: Company Snapshot
Table 51. Omron Corporation: Business Segmentation
Table 52. Pixium Vision: Company Snapshot
Table 53. Pixium Vision: Product Portfolio
Table 54. Second Sight Medical Products Inc: Company Snapshot
Table 55. Second Sight Medical Products Inc: Product Portfolio
Table 56. SetPoint Medical: Company Snapshot
Table 57. Sonova Holding AG: Company Snapshot
Table 58. Sonova Holding AG: Main Brands and Products
Table 59. St. Jude Medical, Inc.: Company Snapshot
Table 60. Stimwave LLC: Company Snapshot
Table 61. Stimwave LLC: Product Portfolio
Table 62. Risk Evaluation for Investing in North America Market, 2020-2030
Table 63. Critical Success Factors and Key Takeaways
Table 1. Snapshot of North America Bioelectric Medicine Market in Balanced Perspective, 2020-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Projection of North America Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Selected Examples of Product Recalls
Table 6. Main Product Trends and Market Opportunities in North America Bioelectric Medicine Market
Table 7. North America Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 8. North America Implantable Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 9. North America Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, $ mn
Table 10. North America Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, $ mn
Table 11. North America Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, $ mn
Table 12. North America Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 13. North America Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 14. North America Bioelectric Medicine Market by Country, 2019-2030, $ mn
Table 15. U.S. Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 16. U.S. Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 17. Canada Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 18. Canada Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 19. Mexico Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 20. Mexico Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 21. Spinal Cord Stimulation Device Market by Key Vendor, 2019, %
Table 22. Cochlear Implant Market by Key Vendor, 2019, %
Table 23. Pacemaker and ICD Market by Key Vendor, 2019, %
Table 24. FDA Approved Products of Key Vendors
Table 25. Abbott Laboratories: Company Snapshot
Table 26. Abbott Laboratories: Business Segmentation
Table 27. Abbott Laboratories: Product Portfolio
Table 28. Abbott Laboratories: Revenue, 2018-2020, $ mn
Table 29. BIOTRONIK SE & Co. KG: Company Snapshot
Table 30. Boston Scientific Corp.: Company Snapshot
Table 31. Boston Scientific Corp.: Business Segmentation
Table 32. Boston Scientific Corp.: Product Portfolio of Medical Devices
Table 33. Cochlear Limited: Company Snapshot
Table 34. Cochlear Limited: Operational Overview with Sales Revenue ($ mn) and Sales Volume (units), 2020-2021
Table 35. Cochlear Limited: Product Portfolio
Table 36. electroCore, Inc.: Company Snapshot
Table 37. Inspire Medical Systems, Inc..: Company Snapshot
Table 38. LivaNova PLC: Company Snapshot
Table 39. LivaNova PLC: Product Portfolio
Table 40. Medtronic Inc.: Company Snapshot
Table 41. Medtronic Inc.: Net Revenue by Segment, 2018-2020, $ bn
Table 42. Medtronic Inc.: Net Revenue by Region, 2017-2019, $ bn
Table 43. Medtronic Inc.: Product Portfolio of Medical Devices
Table 44. Medtronic Inc.: Product Portfolio of Bioelectric Medicine
Table 45. NeuroMetrix, Inc: Company Snapshot
Table 46. NeuroMetrix, Inc: Product Portfolio
Table 47. Nevro Corp.: Company Snapshot
Table 48. Nevro Corp.: Product Portfolio
Table 49. Nuvectra Corporation: Company Snapshot
Table 50. Omron Corporation: Company Snapshot
Table 51. Omron Corporation: Business Segmentation
Table 52. Pixium Vision: Company Snapshot
Table 53. Pixium Vision: Product Portfolio
Table 54. Second Sight Medical Products Inc: Company Snapshot
Table 55. Second Sight Medical Products Inc: Product Portfolio
Table 56. SetPoint Medical: Company Snapshot
Table 57. Sonova Holding AG: Company Snapshot
Table 58. Sonova Holding AG: Main Brands and Products
Table 59. St. Jude Medical, Inc.: Company Snapshot
Table 60. Stimwave LLC: Company Snapshot
Table 61. Stimwave LLC: Product Portfolio
Table 62. Risk Evaluation for Investing in North America Market, 2020-2030
Table 63. Critical Success Factors and Key Takeaways
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2030
Figure 4. North America Bioelectric Medicine Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Bioelectric Medicine Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 8. World Population 65 and over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of North America Bioelectric Medicine Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of North America Bioelectric Medicine Market
Figure 12. Breakdown of North America Bioelectric Medicine Market by Product Type, 2020-2030, % of Sales Revenue
Figure 13. North America Addressable Market Cap in 2021-2030 by Product Type, Value ($ mn) and Share (%)
Figure 14. North America Bioelectric Medicine Market: Implantable Bioelectric Medicine, 2019-2030, $ mn
Figure 15. North America Bioelectric Medicine Market: Cardiac Pacemaker, 2019-2030, $ mn
Figure 16. North America Bioelectric Medicine Market: Implantable Cardioverter Defibrillators (ICD), 2019-2030, $ mn
Figure 17. North America Bioelectric Medicine Market: Spinal Cord Stimulators, 2019-2030, $ mn
Figure 18. North America Bioelectric Medicine Market: Cochlear Implants, 2019-2030, $ mn
Figure 19. North America Bioelectric Medicine Market: Deep Brain Stimulators, 2019-2030, $ mn
Figure 20. North America Bioelectric Medicine Market: Vagus Nerve Stimulators, 2019-2030, $ mn
Figure 21. North America Bioelectric Medicine Market: Sacral Nerve Stimulators, 2019-2030, $ mn
Figure 22. North America Bioelectric Medicine Market: Retinal Implants, 2019-2030, $ mn
Figure 23. North America Bioelectric Medicine Market: Other Implantable Bioelectric Medicines, 2019-2030, $ mn
Figure 24. North America Bioelectric Medicine Market: Non-invasive Bioelectric Medicine, 2019-2030, $ mn
Figure 25. North America Bioelectric Medicine Market: Transcutaneous Electrical Nerve Stimulators, 2019-2030, $ mn
Figure 26. North America Bioelectric Medicine Market: Transcranial Magnetic Stimulation (TMS), 2019-2030, $ mn
Figure 27. North America Bioelectric Medicine Market: Pulsed Electromagnetic Field Therapy, 2019-2030, $ mn
Figure 28. North America Bioelectric Medicine Market: Other Non-invasive Bioelectric Medicines, 2019-2030, $ mn
Figure 29. Breakdown of North America Bioelectric Medicine Market by End User, 2020-2030, % of Sales Revenue
Figure 30. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 31. North America Bioelectric Medicine Market: Hospitals and Clinics, 2019-2030, $ mn
Figure 32. North America Bioelectric Medicine Market: Research Institutes, 2019-2030, $ mn
Figure 33. North America Bioelectric Medicine Market: Individual Users, 2019-2030, $ mn
Figure 34. Breakdown of North America Bioelectric Medicine Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to North America 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. U.S. Bioelectric Medicine Market, 2019-2030, $ mn
Figure 37. Canada Bioelectric Medicine Market, 2019-2030, $ mn
Figure 38. Bioelectric Medicine Market in Mexico, 2019-2030, $ mn
Figure 39. Growth Stage of North America Bioelectric Medicine Industry over the Forecast Period
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2030
Figure 4. North America Bioelectric Medicine Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Bioelectric Medicine Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 8. World Population 65 and over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of North America Bioelectric Medicine Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of North America Bioelectric Medicine Market
Figure 12. Breakdown of North America Bioelectric Medicine Market by Product Type, 2020-2030, % of Sales Revenue
Figure 13. North America Addressable Market Cap in 2021-2030 by Product Type, Value ($ mn) and Share (%)
Figure 14. North America Bioelectric Medicine Market: Implantable Bioelectric Medicine, 2019-2030, $ mn
Figure 15. North America Bioelectric Medicine Market: Cardiac Pacemaker, 2019-2030, $ mn
Figure 16. North America Bioelectric Medicine Market: Implantable Cardioverter Defibrillators (ICD), 2019-2030, $ mn
Figure 17. North America Bioelectric Medicine Market: Spinal Cord Stimulators, 2019-2030, $ mn
Figure 18. North America Bioelectric Medicine Market: Cochlear Implants, 2019-2030, $ mn
Figure 19. North America Bioelectric Medicine Market: Deep Brain Stimulators, 2019-2030, $ mn
Figure 20. North America Bioelectric Medicine Market: Vagus Nerve Stimulators, 2019-2030, $ mn
Figure 21. North America Bioelectric Medicine Market: Sacral Nerve Stimulators, 2019-2030, $ mn
Figure 22. North America Bioelectric Medicine Market: Retinal Implants, 2019-2030, $ mn
Figure 23. North America Bioelectric Medicine Market: Other Implantable Bioelectric Medicines, 2019-2030, $ mn
Figure 24. North America Bioelectric Medicine Market: Non-invasive Bioelectric Medicine, 2019-2030, $ mn
Figure 25. North America Bioelectric Medicine Market: Transcutaneous Electrical Nerve Stimulators, 2019-2030, $ mn
Figure 26. North America Bioelectric Medicine Market: Transcranial Magnetic Stimulation (TMS), 2019-2030, $ mn
Figure 27. North America Bioelectric Medicine Market: Pulsed Electromagnetic Field Therapy, 2019-2030, $ mn
Figure 28. North America Bioelectric Medicine Market: Other Non-invasive Bioelectric Medicines, 2019-2030, $ mn
Figure 29. Breakdown of North America Bioelectric Medicine Market by End User, 2020-2030, % of Sales Revenue
Figure 30. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 31. North America Bioelectric Medicine Market: Hospitals and Clinics, 2019-2030, $ mn
Figure 32. North America Bioelectric Medicine Market: Research Institutes, 2019-2030, $ mn
Figure 33. North America Bioelectric Medicine Market: Individual Users, 2019-2030, $ mn
Figure 34. Breakdown of North America Bioelectric Medicine Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to North America 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. U.S. Bioelectric Medicine Market, 2019-2030, $ mn
Figure 37. Canada Bioelectric Medicine Market, 2019-2030, $ mn
Figure 38. Bioelectric Medicine Market in Mexico, 2019-2030, $ mn
Figure 39. Growth Stage of North America Bioelectric Medicine Industry over the Forecast Period
